NIH Director's Blog: Drug Development

MARCH 18, 2021

These days, the Veesler lab has been hard at work to understand SARS-CoV-2 and the human immune response to the virus. He’s also a member of the international research team that identified a human antibody, called S309, from a person who’d been infected with SARS in 2003.

Virus 52

Virus Immune Response Clinical Trials Treatment 52

NIH Director's Blog: Drug Development

MAY 21, 2020

In work described in the journal Nature , an international research team started with a set of neutralizing antibodies previously identified in a blood sample from a person who’d recovered from a different coronavirus-caused disease, called severe acute respiratory syndrome (SARS), in 2003 [3]. In the U.S. medRxiv.

Virus 52

Virus Vaccine Laboratories Science 52

Drug Target Review

FEBRUARY 14, 2025

The KEGG Pathway database provides insights into metabolic pathways, genetic interactions and disease mechanisms, which are crucial for understanding how a dataset can inform our understanding of complex biological phenomena such as signal transduction, cell proliferation, or immune responses.

Drugs 52

Drugs Research Immune Response Science 52